NEW YORK (GenomeWeb) – Sygnis said today that it has signed a non-exclusive distribution agreement for its TruePrime product family with Ozyme France.
Under the terms of the agreement, Ozyme will be able to promote, market, and sell existing and future TruePrime products to molecular biologists in France.
TruePrime products combine Sygnis' recently discovered DNA primase TthPrimPol and the Phi29 polymerase, and enable the amplification of total genomic DNA from exceedingly small amounts of sample, down to the single-cell level, without requiring synthetic primers.
Sygnis has also signed distribution agreements for its TruePrime products with Funakoshi, BioNova, D-Mark, and BioCat in recent months.